Post placeholder image
November 10, 2022 in Kineta Press Release

Kineta Announces Effectiveness of Registration Statement on Form S-4 in Connection with Proposed Reverse Merger with Yumanity Therapeutics (YMTX)

Special Meeting of stockholders to approve asset sale and merger to be held on December 13, 2022 BOSTON, Nov. 10, 2022 -- Yumanity Therapeutics, Inc. ("Yumanity" or the "Company") (Nasdaq: YMTX) ...

Read More